DRTS.US Alpha Tau Medical Ltd

Healthcare Biotechnology USA Stocks
13.38 USD
Close of Nov 14, 2026
3.43 15.79
Market cap
USD 1.24B
P/E
-
P/B
28.04x
ROE
-312.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is DRTS.US undervalued?

Graham number

The Graham number of Alpha Tau Medical Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Alpha Tau Medical Ltd fundamental analysis

No fundamental analysis for Alpha Tau Medical Ltd yet.

Alpha Tau Medical Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Alpha Tau Medical Ltd

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic colla…

Full company profile